Transformative Research in Diabetic Nephropathy 2.0
Transformative Research in Diabetic Nephropathy 2.0
Recruiting · NCT07444203 · Registry updated 2026-03-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Transformative Research in Diabetic Nephropathy 2.0 | Chronic Disease, Diabetes Complications, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, diabetes mellitus, diabetic kidney disease, endocrine system disorder, glucose metabolism disease, kidney disorder, kidney failure, metabolic disease, type 2 diabetes mellitus, urinary system disorder | Recruiting | Not stated | 2026-03-02 | NCT07444203 |
7 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Boehringer Ingelheim | 158 |
| Genentech, Inc. | 221 |
| GlaxoSmithKline | 294 |
| Novo Nordisk A/S | 181 |
| Regeneron Pharmaceuticals | 238 |
| University of Pennsylvania | 502 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Penn Presbyterian Medical Center | Philadelphia | United States | 44 |